nach oben

Erschienen in:

01.11.2016 | Original Article

Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis

verfasst von: A. M. Walling, S. C. Ahluwalia, N. S. Wenger, M. Booth, C. P. Roth, K. Lorenz, F. Kanwal, S. Dy, S. M. Asch, the Palliative Care Cirrhosis Quality Expert Panel

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

There are guidelines for the medical management of cirrhosis and associated quality indicators (QIs), but QIs focusing on standards for palliative aspects of care are needed.

Methods

We convened a 9-member, multidisciplinary expert panel and used RAND/UCLA modified Delphi methods to develop palliative care quality indicators for patients with cirrhosis. Experts were provided with a report based on a systematic review of the literature that contained evidence concerning the proposed candidate QIs. Panelists rated QIs prior to a planned meeting using a standard 9-point RAND appropriateness scale. These ratings guided discussion during a day-long phone conference meeting, and final ratings were then provided by panel members. Final QI scores were computed and QIs with a final median score of greater than or equal to 7, and no disagreement was included in the final set.

Results

Among 28 candidate QIs, the panel rated 19 as valid measures of quality care. These 19 quality indicators cover care related to information and care planning (13) and supportive care (6).

Conclusions

These QIs are evidence-based process measures of care that may be useful to improve the quality of palliative care. Research is needed to better understand the quality of palliative care provided to patients with cirrhosis.

Nur mit Berechtigung zugänglich

Walling AM, Asch SM, Lorenz KA, et al. The quality of care provided to hospitalized patients at the end of life. Arch Intern Med. 2010;170:1057–1063.CrossRefPubMedPubMedCentral

Teno JM, Gozalo PL, Bynum JP, et al. Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000 2005, and 2009. JAMA. 2013;309:470–477.CrossRefPubMedPubMedCentral

Meier DE. Increased access to palliative care and hospice services: opportunities to improve value in health care. Milbank Q. 2011;89:343–380.CrossRefPubMedPubMedCentral

Wachterman MW, Pilver C, Smith D, et al. Quality of end-of-life care provided to patients with different serious illnesses. JAMA Intern Med. 2016;176:1095–1102.CrossRefPubMed

Kamal AH, Gradison M, Maguire JM, et al. Quality measures for palliative care in patients with cancer: a systematic review. J Oncol Pract. 2014;10:281–287.CrossRefPubMedPubMedCentral

Action Plan for Liver Disease Research: National Institute of Diabetes and Digestive Diseases and Kidney Disease http://www2.niddk.nih.gov/AboutNIDDK/ResearchAndPlanning/Liver_Disease/ActionPlanforLiverDiseaseResearchSlidesMinutes.htm. Last Accessed August 12, 2013.

UNOS Donate Life America Statistics. http://donatelife.net/understanding-donation/statistics/. Last Accessed December 30, 2014.

Larson AM, Curtis JR. Integrating palliative care for liver transplant candidates: “too well for transplant, too sick for life”. JAMA. 2006;295:2168–2175.CrossRefPubMed

Roth K, Lynn J, Zhhong Z, et al. Dying with end stage liver disease with cirrhosis: Insights from SUPPORT. J Am Geriatr Soc. 2000;48:S122–S130.CrossRefPubMed

10.

Younossi ZM, Bopari N, Price L, et al. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96:2199–2205.CrossRefPubMed

11.

Kanwal F, Kramer J, Asch S, et al. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010;8:709–717.CrossRefPubMed

12.

The RAND/UCLA appropriateness method user’s manual. Santa Monica, CA, RAND Corporation, 2001.

13.

Shekelle PG, Chassin MR, Park RE. Assessing the predictive validity of the RAND/UCLA appropriateness method criteria for performing carotid endarterectomy. Int J Technol Assess Health Care. 1998;14:707–727.CrossRefPubMed

14.

Zigmond DS, Ettner SL, Wilber KH, Wenger NS. Association of claims-based quality of care measures with outcomes among community-dwelling vulnerable elders. Med Care. 2011;49:553–559.CrossRef

15.

Higashi T, Shekelle PG, Adams JL, et al. Quality of Care is associated with survival in vulnerable older patients. Ann Intern Med. 2005;143:274–281.CrossRefPubMed

16.

Shekelle P. The appropriateness method. Medical Decision Making. 2004;24:228–231.CrossRefPubMed

17.

Kahn KL, Tisnado DM, Adams JL, et al. Does Ambulatory process of care predict health related quality of life outcomes for patients with chronic disease. Health Serv Res. 2007;42:63–83.CrossRefPubMedPubMedCentral

18.

National Consensus Project for Quality Palliative Care. Clinical practice guidelines for quality palliative care. Executive summary. J Palliat Med. 2004;7:611–627.CrossRef

19.

National Quality Forum. NQF endorses palliative and end-of-life care measures. http://www.qualityforum.org/News_And_Resources/Press_Releases/2012/NQF_Endorses_Palliative_and_End-of-Life_Care_Measures.aspx. Accessed August 15, 2013.

20.

Spengler U. Management of end-stage liver disease in HIV/hepatitis C virus co-infection. Curr Opin HIV AIDS. 2011;6:527–533.CrossRefPubMed

21.

Perumalswami PV, Schiano TD. The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci. 2011;56:1266–1281.CrossRefPubMed

22.

Hansen L, Sasaki A, Zucker B. End stage liver disease: challenges and practical implications. Nurs Clin North Am. 2010;45:411–426.CrossRefPubMed

23.

Garcia-Tsao G, Lim JK. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802–1829.CrossRefPubMed

24.

Heidelbaugh JJ, Sherbondy M. Cirrhosis and chronic liver failure: part II. Complications and treatment. Am Fam Physician. 2006;74:767–776.PubMed

25.

Soncini M, Leo P, Triossi O, et al. Management and outcomes of hepatic cirrhosis: Findings from the RING study. Hepatol Rs. 2006;36:176–181.CrossRef

26.

Sanchez W, Talwalkar JA. Palliative care for patients with end-stage liver disease ineligible for liver transplantation. Gastroenterol Clin North Am. 2006;55:201–219.CrossRef

27.

Lorenz KA, Rosenfeld K, Wenger NS. Quality indicators for palliative and end-of-live care in vulnerable elders. JAGS. 2007;55:S318–S326.CrossRef

28.

Lorenz KA, Dy SM, Naeim A, et al. Quality measures for supportive cancer care: The Cancer Quality-ASSIST Project. J Pain Symptom Manage. 2009;37:943–964.CrossRefPubMed

29.

Temel JS, Greer JA, Muzikansky A, et al. Early palliative care in patients with metastatic non-small cell lung cancer. NEJM. 2010;363:733–742.CrossRefPubMed

30.

Higginson IJ, Finlay IG, Goodwin DM, et al. Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers? J Pain Symptom Manag. 2003;25:150–168.CrossRef

31.

Bakitas M, Lyons Hegel MT, et al. Effects of palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA. 2009;302:741–749.CrossRefPubMedPubMedCentral

32.

Walling AM, et al. Evidence-based recommendations for information and care planning in cancer care. J Clin Oncol. 2008;23:3896–3902.CrossRef

33.

Wright AA, Zhang AA, Huskamp H, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300:1665–1673.CrossRefPubMedPubMedCentral

34.

Zimmermann C, Swami N, Krzyzanowskam M, et al. Early palliative care for patients with advanced cancer: a cluster-randomized controlled trial. Lancet. 2014;383:1721–1730.CrossRefPubMed

35.

Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291:89–93.CrossRef

36.

Walling AM, Asch SM, Lorenz KA, Wenger NS. Impact of consideration of transplantation on end-of-life care for patients during a terminal hospitalization. Transplantation. 2013;95:641–646.CrossRefPubMed

Titel: Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis
verfasst von: A. M. Walling
S. C. Ahluwalia
N. S. Wenger
M. Booth
C. P. Roth
K. Lorenz
F. Kanwal
S. Dy
S. M. Asch
the Palliative Care Cirrhosis Quality Expert Panel
Publikationsdatum: 01.11.2016
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 1/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-016-4339-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis

Abstract

Background and Aims

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background and Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Mental Illness Is Not Associated with Adherence to Colorectal Cancer Screening: Results from the California Health Interview Survey

Contraceptive Considerations for Women with Gastrointestinal Disorders

Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV

Erratum to: Hereditary Angioedema Presenting with Recurrent Ascites

Nitric Oxide and Hydrogen Sulfide Interact When Modulating Gastric Physiological Functions in Rodents

Pulmonary Crohn’s Disease

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin